TFF Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TFFP Nasdaq 8731 https://tffpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TFF Pharmaceuticals Inc

TFF Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference - May 23rd, 2023 8:05 pm
TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results - May 11th, 2023 8:05 pm
Sidoti's Micro-Cap Virtual May Conference - May 9th, 2023 11:15 am
TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases - May 4th, 2023 12:00 pm
TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program - May 1st, 2023 11:00 am
We're A Little Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Rate - Apr 8th, 2023 12:58 pm
TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results - Mar 7th, 2023 9:15 pm
TFF Pharmaceuticals to Participate in the 35th Annual Roth Conference - Mar 6th, 2023 9:05 pm
3 Bargain Stocks Worth Buying at These 52-Week Lows - Feb 23rd, 2023 6:01 pm
TFF Pharmaceuticals Appoints Harlan Weisman, M.D. as Permanent Chief Executive Officer - Feb 8th, 2023 9:05 pm
TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer - Jan 9th, 2023 1:00 pm
TFF Pharmaceuticals Announces Leadership Transition - Dec 5th, 2022 11:30 am
TFF Pharmaceuticals Announces Closing of $12.3 Million Public Offering - Nov 29th, 2022 9:01 pm
15 Most Volatile Stocks to Buy Now - Nov 21st, 2022 6:40 pm
TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and Warrants - Nov 18th, 2022 1:00 pm
TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants - Nov 17th, 2022 9:01 pm
TFF Pharmaceuticals Third Quarter 2022 Earnings: US$0.29 loss per share (vs US$0.34 loss in 3Q 2021) - Nov 17th, 2022 10:34 am
TFF Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update - Nov 14th, 2022 9:01 pm
TFF Pharmaceuticals to Hold Third Quarter 2022 Financial and Business Results Conference Call on November 14, 2022 - Nov 7th, 2022 9:05 pm
TFF Pharmaceuticals Announces Collaboration with Aptar Pharma to Explore and Develop Intranasal Delivery of Dry Powder Vaccines and Dry Powder Therapeutics - Nov 3rd, 2022 12:00 pm